心不全における緩和ケア：欧州心臓病学会の心不全協会の緩和ケアワークショップからの見解
2009年のポジションステートメント。
なんか、いまだにこれが全てな気がする！！
onlinelibrary.wiley.com/doi/full/10.10…

'...patients with chronic heart failure who agree in principle to take part in clinical trials have a better prognosis than those who do not...

We have not found any obvious systematic difference between the patient groups to explain these findings.'

onlinelibrary.wiley.com/doi/10.1093/eu…

みなさんにatrial dyssynchronyをお知らせします。

onlinelibrary.wiley.com/doi/full/10.10…

#サマキャン2022

Eurjhf

Get out (on time) and Keep out (indefinitely):
Risk following hospitalization in stable chronic systolic heart failure

onlinelibrary.wiley.com/doi/full/10.10…

#ESCcongress #WCC2019

Study recap: “Paced QRS duration” as predictor for cardiac dysfunction #heartfailure during right ventricular apical pacing in patients with idiopathic complete AVB: the PREDICT-HF observation, #EPeeps #pacemaker #cardiotwitter onlinelibrary.wiley.com/doi/full/10.10…

Those who say yes, have better outcomes EVEN IF THERE IS NO TRIAL and you are just asking them in principle if they would consider being in a trial.

Shocking but actually true ... Here is Andrew Clark showing this in Heart Failure
onlinelibrary.wiley.com/doi/10.1093/eu…

A personal favorite #TeamMRA

And let’s not forget, the earlier that MRA gets started (<7 days), the better!

onlinelibrary.wiley.com/doi/full/10.10…

Very recent evidence for my previous tweet! #HeartFailureAwarenessDay #EurJHF twitter.com/matthewsperrin…

Prof. Eva Piotrowicz talks about the possibilities of #ehealth to manage #hypertension in #HeartFailure

#ESCCongress

Read more on eHealth and #Telemedicine in the European Society of Cardiology Journals

goo.gl/VMqma5
bit.ly/2PDVRky

Personalized lifetime prediction of survival and treatment benefit in patients with HFrEF: The LIFE-HF model

A really interesting new paper is online in the European Society of Cardiology Journals #EurJHF with involvement from the University of Glasgow Heart Failure Research Group team

onlinelibrary.wiley.com/doi/10.1002/ej…

【収縮障害心不全に対するβ遮断薬──、服用開始４か月後の安静時心拍数が予後予知因子。58〜64/分で、生命予後最良：657例3年間追跡】
Eur J Heart Fail　bit.ly/NuNCB0

【AFとCHF併発例、──AF先発の割合は75%。CHF先発と予後に有意差。16か月間の死亡・心血管系入院は49.6%（CHF先発 77.7%, p=0.001).：連続182例観察】
Eur J Heart Fail bit.ly/LeTLQh

【洞調律心不全 [EF≦45%] に対するジゴキシン——、NYHA III以上、EFi＜25%、あるいはCRT>55%の高リスク群では、死亡・全入院が有意に減少：DIGサブ解析】
Eur J Heart Fail bit.ly/WXWAKD
後付け解析にあらず

【心房細動、拡張障害心不全では高NT-pri BNP濃度、死亡・入院のリスクを有意増加。収縮障害心不全では、AFとNT-proBNP濃度、予後に有意相関なし：900例強18か月追跡】Eur Heart J goo.gl/tw9ua ６月にonline公開済み

eurjhf.oxfordjournals.org/content/14/10/…

Andreas Gevaert 1/2 I would go with following:
doi.org/10.3389/fphys.…
Sack et al. one of the first papers systematically investigating the role of interventricular interedependence during LVAD support

DOI: 10.1093/eurjhf/hfq006
Lund et al. discussing risks for RV failure following LVAD

【高血圧性心機能低下例の62%に、心筋炎様の組織変化：1229例中、高血圧性と考えられた45例検討】
Eur J Heart Fail bit.ly/T9T91Y

【拡張障害心不全に対するBNP目安の加療——、症状目安に比べ予後増悪の可能性：TIME-CHFサブ解析 [123例]】
Eur J Heart Fail bit.ly/11p1XKx

In the conversation about #NTproBNP , its elevation identifies those with #HFpEF with a prognosis similar to those with #HFrEF European Society of Cardiology Journals #ejhf EJHF Editor-in-Chief Frederik H. Verbrugge Henry Han Mark Petrie British Society for Heart Failure #theFword #CardioTwitter
doi.org/10.1093/eurjhf…